Eli Lilly & Co. (NYSE:LLY)

Big Pharma Sees a Rising Tide in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Big Pharma Short Sellers Hike Their Bets

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

How Eli Lilly Is Making Insulin More Affordable

Drug companies have been decried in the United States for high prices, but Eli Lilly and Co. (NYSE: LLY) is looking to fight this trend — at least a little. ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

2 Pharma Giants Shine as Wall Street Brings Strong IPOs for Cortexyme and NextCure

It may seem like a time of uncertainty for companies producing drugs if they have to include the prices if they advertise those drugs to the public. Some companies always will ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Best Buy, Eli Lilly, Hilton, Hyatt, Kraft Heinz, Procter & Gamble, Snap and More

Stocks were indicated to open higher on Wednesday after the S&P 500 and Nasdaq crossed over all-time highs on Tuesday. With double-digit gains already seen so far in 2019, investors ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Chipotle, CEMEX, CVS, Eli Lilly, Hewlett Packard Enterprise, IBM, Incyte, MercadoLibre, US Steel and More

Stocks were indicated to open marginally higher on Thursday, but not be enough of a line to feel like the day's direction has been set. The market has been choppy ...
Read Full Story »

Unbelievable Swings in Big Pharma Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Sees a Few Wild Swings in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Sell-Off or Not, 7 Blue Chips and Industry Leaders Analysts Want You to Buy Now

The week of March 22, 2019, ended on a very sour note with the Dow Jones industrials selling off on Friday alone by a sharp 460 points and the S&P ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

Stocks were indicated to open marginally higher on Wednesday ahead of the FOMC decision on interest rates. With the market having recouped so much ground in 2019, investors need to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AEP, Apple, Boeing, Coca-Cola, Eli Lilly, RingCentral, Tellurian, Tesla, Vonage and More

Stocks were mixed and looking for direction on Tuesday after Monday's rally. Despite last week's selling pressure, it is important to keep in mind that the Dow Jones industrials had ...
Read Full Story »

Big Pharma Short Interest Backs Off, With One Huge Exception

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 6 Most Shorted NYSE Stocks

After the strong start to the year, the momentum in the big U.S. stock indexes began to slow late in February. Trade concerns and fears of inflation or another recession ...
Read Full Story »